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Objective: To study the value of a single antral follicle count and the additional value of repeated counts in
different cycles for the prediction of poor ovarian response in IVF.
Design: Prospective.
Setting: Tertiary fertility center.
Patient(s): One hundred twenty women undergoing their first IVF cycle.
Intervention(s): Measurement of the number of antral follicles on cycle day 3 in two spontaneous cycles.
Main Outcome Measure(s): Ovarian response.
Result(s): A single antral follicle count is clearly predictive of poor ovarian response and there is good
agreement between repeated measurements in subsequent cycles (area under the receiver operating charac-
teristic curve [ROCAUC]; cycle 1: 0.87, cycle 2: 0.85). In a logistic regression analysis, information obtained
after the second cycle contributed significantly to the prediction of poor response by the antral follicle count
of the first cycle. The predictive accuracy of the highest of two counts (ROCAUC 0.89) was slightly better than
that of each single count. The predictive model with the highest count yielded slightly higher values of
specificity and positive predictive value. Sensitivity, negative predictive value, and error rates were slightly
lower.
Conclusion(s): A single antral follicle count is a good predictor of poor ovarian response in IVF. Although
the impact of a second antral follicle count on ovarian response predictions in IVF is statistically significant,
clinical relevance is very limited. Repeating an antral follicle count in a subsequent cycle is not recommended.
(Fertil Steril 2004;81:35–41. ©2004 by American Society for Reproductive Medicine.)
Key Words: Antral follicle count, IVF, ovarian reserve, poor response, repeated measurements
Delayed childbearing warrants a continuous
focus on the phenomenon of reproductive ag-
ing. Aging of the ovary seems to play a key
role in this process, which comprises both pri-
mordial follicle reduction and oocyte quality
deterioration. The remaining follicle pool and
its quality is usually referred to as ovarian
reserve.
In an IVF program, ovarian aging is char-
acterized by lowered pregnancy rates and
decreased ovarian responsiveness to gonado-
tropin administration. The so-called poor re-
sponders are likely to suffer from diminished
ovarian reserve and consequently have im-
paired pregnancy prospects due to loss of oo-
cyte quality. Early identification of patients
who will react insufficiently to ovarian stimu-
lation is, therefore, of great value for adequate
counseling and perhaps also for the choice of
the best stimulation regimen.
As a prognosticator of individual ovarian
potential, chronological age is of limited value
because women of the same age can be at
different stages in the process of follicular de-
pletion. This feature is also related to the wide
range of age at onset of menopause, which
marks “total” follicular depletion (1). Basal
FSH has been shown to be a better marker of
individual ovarian reserve than age (2), and is
to date commonly used in many infertility cen-
ters. As a predictor of ovarian response in IVF,
basal FSH generally demonstrates a fair per-
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formance. However, with regard to subsequent pregnancies
its predictive ability is quite limited (3, 4). An adequate test
for individual reproductive potential is yet to be established.
Several other endocrine ovarian reserve tests were pro-
posed in the past decade. Also from the field of quantitative
ultrasonography achievements in the development of tests
that assess ovarian reserve have been reported on. Syrop et
al. (5, 6) introduced ovarian volume as a prognosticator for
IVF outcome. After the finding of Ruess et al. (7), that the
number of antral follicles in healthy volunteers declined with
increasing age, several studies on the relation between the
number of small antral follicles and response to ovarian
stimulation in patients undergoing assisted reproduction
have been performed (8, 9). Low numbers of small antral
follicles are associated with decreased ovarian response dur-
ing controlled ovarian hyperstimulation (COH) before IVF,
supporting the concept of a reduced primordial follicle pool
delivering a small antral follicle cohort. The study by Chang
et al. (8) also showed a trend toward lower pregnancy rates
in women with few antral follicles. However, this trend
lacked significance, probably due to the limited size of the
population under study.
Scheffer et al. (10) addressed the issue of intercycle
variation in the number of antral follicles in fertile volunteers
and found a rather wide 95% coverage interval around the
mean difference between repeated measurements. If the
same were the case in infertility patients, this might influence
the predictive performance of the number of antral follicles
toward ovarian response in IVF. Therefore, the aim of this
study was to investigate the predictive accuracy of single and
repeated antral follicle counts in the prediction of poor
ovarian response and to assess the degree of agreement
between antral follicle counts in subsequent cycles.
MATERIALS AND METHODS
Patients
In this study 130 patients, who were referred to our IVF
clinic for their first IVF cycle in this pregnancy attempt, were
included prospectively. All patients met the following crite-
ria: [1] regular spontaneous menstrual cycle (25–35 days);
[2] presence of both ovaries; [3] no evidence of endocrine
disorders (normal levels of TSH, T, androstenedione (A),
and PRL); and [4] written informed consent.
The institutional review board approved of the study.
Patients were classified according to the main cause of
infertility (tubal, male, or unexplained). In the majority of
patients conventional IVF was planned (n  112), whereas
the remaining 18 patients were scheduled for intracytoplas-
matic sperm injection (ICSI).
The currently presented study is part of a larger investi-
gation on the relationship between various ovarian reserve
markers and IVF outcome. Data on the predictive perfor-
mance of multiple basal markers of ovarian reserve toward
IVF outcome were published previously (11). Baseline data
of patient characteristics and treatment variables were drawn
from this study and reprinted by permission from the Amer-
ican Society for Reproductive Medicine.
Transvaginal Ultrasonography
On day 3 of a spontaneous cycle, and again on day 3 of
the second subsequent cycle, ovarian ultrasonography was
performed using a Toshiba Capasee SSA-220A (Toshiba
Medical Systems Europe BV, Zoetermeer, The Netherlands)
with a 7.5-MHz transvaginal probe. Round or oval echo-free
structures were regarded as follicles and all follicles up to 5
mm were included in the data analysis as the antral follicle
count.
One investigator (LB) performed all ultrasound measure-
ments.
Hormone Assay
During ovarian stimulation for IVF, plasma concentra-
tions of E2 were assayed with a monoclonal enzyme immu-
noassay from Abbott Laboratories (Abbott Park, IL) on the
semiautomated IMx analyzer. Between run coefficients of
variation were 10.1%, 7.0%, and 6.9% at 533, 1,354, and
4,197 pmol/L, respectively (n  49, 49, and 30).
Treatment Protocol
The IVF was conducted within 3 months from the antral
follicle counts. A detailed description of the protocol was
published previously (12). In short, in all patients a long
protocol of down-regulation with 1 mg of leuprolide acetate
daily (Lucrin; Abbott, Hoofddorp, The Netherlands) was
applied from the midluteal phase onward, followed by ovar-
ian stimulation with follitropin alpha (Gonal-F; Serono
Benelux BV, s Gravenhage, The Netherlands) in a fixed
daily dose of 150 IU. Stimulation was monitored by trans-
vaginal ultrasonography and E2 measurements. After 7 days
the gonadotropin dose was adjusted individually.
After the development of at least three leading follicles
hCG (Profasi; Serono Benelux BV) was administered and a
transvaginal, ultrasound-guided oocyte retrieval was per-
formed 36 hours later. The maximum number of embryos at
transfer was either two (women38 years) or three (women
38 years). The luteal phase was supported by hCG (Pro-
fasi) if the peak E2 level was 10,000 pmol/L and if 15
oocytes were harvested. In all other cases micronized P
(Progestan; Nourypharma BV, Oss, The Netherlands) was
applied.
Ovarian Response
To date, there is no uniform definition of poor response
(4, 13). In a recent study, when changing the cutoff level of
the number of ultrasonographically visible follicles at oocyte
retrieval to define poor response from 2 to 5, the results of
comparisons of patient characteristics and treatment out-
come between poor and normal responders were similar
(14).
36 Bancsi et al. Repeated antral follicle counts Vol. 81, No. 1, January 2004
At a mean fertilization rate of 50%–60% in IVF, retrieval
of four oocytes would be needed to reach an average of two
embryos available for transfer. Thus, in this study we defined
poor response as: [1] collection of fewer than four oocytes at
retrieval or [2] cycle cancellation due to impaired follicular
reaction (3 follicles) in response to exogenous gonadotro-
pins.
High response was defined as the collection of 20
oocytes at retrieval. Patients whose cycles were canceled
because they were considered at risk of ovarian hyperstimu-
lation syndrome (OHSS) due to exaggerated follicle growth
(30 follicles or peak E2 15,000 pmol/L), were also de-
fined as high responders. In all other cases ovarian response
was classified as normal. For purpose of analysis normal and
high responders were considered as one group.
Pregnancy
Clinical and ongoing pregnancies were defined as the
presence of fetal cardiac activity beyond 6 and 12 weeks of
gestation, respectively. Multiple pregnancies were dealt with
in the same manner as singleton pregnancies.
Eligibility for Analysis
Data of all patients who underwent ovarian stimulation
were analyzed. Patients whose cycles were canceled due to
either risk of OHSS or poor response to hormone stimulation
(3 follicles) were included in ovarian response analyses
but not in pregnancy rate calculations, because it cannot be
excluded that such patients would have become pregnant if
IVF were performed. On the other hand, patients with com-
plete absence of follicle growth and E2 level below the
detection limit of the assay (200 pmol/L) were considered
to have a zero chance of pregnancy. These patients were
included into pregnancy rate calculations and counted as
nonpregnant.
Methods of Analysis
Data were analyzed with the SPSS (SPSS Inc., Chicago,
IL) and General Linear Interactive Modelling packages
(GLIM, NAG, Oxford, United Kingdom) (15). A two-sided
P value .05 was considered to indicate statistical signifi-
cance. We used the Mann Whitney U test, the 2 test, and
Fisher’s exact test for comparison of clinical data and IVF
treatment variables between poor responders and normal
responders. A Wilcoxon signed rank test and Pearson’s
correlates were used to compare antral follicle counts from
the first and second cycle.
Reproducibility of the antral follicle count was analyzed
by calculating the 95% coverage interval of the difference
between two counts (16, 17). The 95% coverage interval is
defined as 1.96*SD above or below the mean difference of
two measurements. Reproducibility was also studied assum-
ing individual-specific average levels and Poisson distrib-
uted variability between individual-specific measurements.
The coverage interval for the difference between two Pois-
son distributed counts is accordingly estimated as 1.96 times
the square root of two times the Poisson mean.
Logistic regression was applied to study the value of
antral follicle counts, age, and infertility diagnosis for the
prediction of poor ovarian response. We also analyzed sev-
eral possible prognostic variables derived from the combi-
nation of the two antral follicle counts: mean, highest, and
lowest antral follicle count.
Multiple logistic regression analysis with forward selec-
tion of parameters was applied, with P.10 for entry. To
assess the predictive power of logistic models, areas under
the receiver operating characteristic curve (ROCAUC) were
computed. Values can range from 0.5 (no predictive power)
to 1 (perfect prediction). The ROCAUC reflects the propor-
tion of all discordant pairs of patients, consisting of one poor
responder and one normal responder, in which the model
predicts a higher probability of poor response for the poor
responder patient than for the normal responder. The predic-
tive performances of the logistic models were further ana-
lyzed in terms of sensitivity, specificity, positive and nega-
tive predictive values, and error rates (total proportion of
patients in whom the occurrence of poor or normal ovarian
response was predicted falsely).
T A B L E 1
Comparison of basic clinical data of normal responders
(NR) and poor responders (PR).
Variable
NR
(n  84)
PR
(n  36) P value
Mean ( SD) age (y) 34.4  4.7 36.2  5.4 .06
Mean ( SD) duration of
infertility (mo)
33  16 39  39 .94
Mean ( SD) body mass index
(kg/m2)
22.9  3.7 24.4  4.2 .10
No. (%) of patients with indicated
type of infertility
Primary 48 (57) 18 (50) .47
Secondary 36 (43) 18 (50)
No. (%) of patients with indicated
infertility diagnosis
Tubal 17 (20) 6 (17) .001
Male 50 (60) 9 (25) .001
Unexplained 17 (20) 21 (58)
Mean ( SD) cycle 1 antral
follicle count (n)
11.6  6.2 4.2  3.3 .001
Mean ( SD) cycle 2 antral
follicle count (n)
11.4  6.3 4.6  3.3 .001
Mean ( SD) mean antral follicle
count (n)
11.5  5.9 4.4  3.2 .001
Mean ( SD) highest antral
follicle count (n)
13.2  6.3 5.1  3.4 .001
Mean ( SD) lowest antral
follicle count (n)
9.9  5.7 3.7  3.1 .001
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RESULTS
Of the 130 included patients, 120 became eligible for
analysis (n  102 for IVF and n  18 for ICSI). Six patients
conceived spontaneously while on the waiting list for IVF,
two patients dropped out due to intercurrent disease, and two
patients withdrew their consent.
A total of 36 patients were diagnosed as poor responders.
In 20 patients follicular aspiration yielded less than four
oocytes and 16 cycles were canceled due to either complete
absence of ovarian response (n  10; included in pregnancy
calculations) or to development of only one or two follicles
during hormone stimulation (n  6; not included in preg-
nancy calculations). Ten patients were diagnosed as high
responders, after either cycle cancellation because of risk of
OHSS (n  7; not included in pregnancy calculations) or
retrieval of more than 20 oocytes (n  3; included in
pregnancy calculations). Thus, of the 120 patients with data
for ovarian response analysis, 107 were included into preg-
nancy calculations.
Table 1 presents basic clinical data for poor responders
and normal responders. Antral follicle counts from cycle 1
and cycle 2 were similar (P.81). All antral follicle vari-
ables were significantly lower in poor responders. The IVF
treatment results are shown in Table 2. Poor responders
showed significantly lower pregnancy rates. The reduced
implantation rate per embryo is more striking, considering
the fact that embryo quality was similar in both groups
(P.28).
There was a good correlation between antral follicle
counts of cycle 1 and cycle 2 (r  0.83). At higher values,
the points deviated more from the line of equality (Fig. 1).
Reproducibility was assessed by plotting mean antral follicle
count against difference in antral follicle counts, as shown in
Figure 2. The mean difference between two measurements
was 0.05. The overall 95% coverage limits of the mean
difference were 7.26 and 7.36. However, Figure 2 shows
increasing variability around the mean difference when the
mean count increases. This pattern of variability is consistent
with the assumption that the two measurements are indepen-
dent Poisson counts (P.14). The corresponding coverage
interval is indicated in Figure 2.
Univariate logistic regression analysis revealed a good
predictive power of all antral follicle count variables for the
prediction of poor response (Table 3). Age and infertility
diagnosis appeared to be far less potent predictors of poor
response. When applying stepwise forward selection on all
variables presented in Table 3, the highest antral follicle
T A B L E 2
IVF treatment results in normal responders (NR) and
poor responders (PR).
Variable NR (n  84) PR (n  36) P value
Mean ( SD) no. of
ampules
25.4  8.9 29.7 10.8 .022
Mean ( SD) duration of
stimulation (d)
12.9  2.9 13.6 3.2 .18
Rate of gonadotropin
dose increase (%)
18 (15) 42 (15) .006
Mean ( SD) peak E2
level (pmol/L)
7594  3779 1696 1661 .001
Mean ( SD) no. of
oocytesa
9.5  4.8 2.1 0.8 .001
Mean ( SD)
fertilization rate (%)
55  32 75 33 .006
Mean ( SD) no. of
embryos per ETb
2.1  0.5 1.7 0.6 .003
Implantation rate per
embryo (%)
30 (41/137) 10 (3/30) .024
Clinical pregnancy rate
(%)c
40 (31/77) 10 (3/30) .003
Ongoing pregnancy rate
(%)c
31 (24/77) 10 (3/30) .024
a Data for oocyte retrieval cycles (overall n  97, normal responders n 
77, and poor responders n  20).
b Data for embryo transfer cycles (overall n  83, normal responders n 
65, and poor responders n  18).
c Data for oocyte retrieval cycles or cycle cancellation due to complete
absence of follicular response (overall n  107, normal responders n  77,
and poor responders n  30).
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F I G U R E 1
Plot of the first antral follicle count against the second antral
follicle count. The solid line represents equality of the two
counts.
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count was selected in the first step and no other variable
contributed significantly thereafter (ROCAUC  0.89,
P.001). To assess whether a second antral follicle count
added significantly to a first count, we performed forced
entry of cycle 1 or cycle 2 antral follicle count before
applying stepwise forward selection. Again, the highest an-
tral follicle count was selected (ROCAUC  0.89, P.03 and
ROCAUC  0.89, P.005, respectively), indicating that the
highest of two counts significantly contributes to the predic-
tion of poor response by each single count. Forced entry of
age and infertility diagnosis did not improve predictive
power.
The clinical performance of the best single predictor after
one measurement (cycle 1 antral follicle count) and the
strongest predictor based on two measurements (highest
antral follicle count) was compared on classic test properties.
To elucidate the influence of changing the cutoff point, we
calculated the test characteristics for several cutoff values of
the number of antral follicles (Table 4). At lower cutoff
points sensitivity and negative predictive value decrease and
specificity and positive predictive value increase. The high-
est antral follicle count displayed better specificity and pos-
itive predictive value, whereas at the same cutoff levels
sensitivity was lower than for cycle 1 antral follicle count.
The error rate is about 2% lower for the highest antral follicle
count.
DISCUSSION
With regard to the relationship between the number of
small antral follicles and ovarian reserve, Gougeon (18)
demonstrated a clear association between the number of
growing follicles and the number of resting follicles in the
follicle pool. Moreover, Pellicer et al. (19) found a high
correlation when comparing numbers of selectable follicles
(2–5 mm) measured by three-dimensional ultrasonography
with the numbers of selectable follicles in histological slices.
Therefore, it is plausible that the number of antral folli-
cles, originating from the cohort of growing follicles,
reflects the size of the pool of resting follicles, and thus
ovarian reserve.
In this study, a single investigator performed all antral
follicle counts. There is evidence that counts of antral folli-
cles are subject to limited interobserver variation only (20).
In addition, we studied interobserver variation for both real-
time two-dimensional transvaginal ultrasonography and
stored three-dimensional transvaginal ultrasound images and
between method variation comparing two- and three-dimen-
sional transvaginal ultrasonography (21). The data indicated
adequate two- and three-dimensional interobserver repro-
ducibility as well as acceptable between method variation.
Therefore, ultrasound-based antral follicle counts seem to be
a reliable tool for the assessment of ovarian reserve and
F I G U R E 2
Plot of mean antral follicle count against difference in antral follicle counts (cycle 1 antral follicle count  cycle 2 antral follicle
count). The solid line represents the mean difference. The dotted line represents the upper and lower limit of the 95% coverage
interval of the mean difference.
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studies on the prediction of poor ovarian response to exog-
enous gonadotropins.
Our data confirm that a single antral follicle count is a
good indicator of the occurrence of poor or normal response
in IVF (8, 22). If poor response is adequately predictable,
then an antral follicle count before IVF could be useful for
patient counseling and perhaps treatment management.
Moreover, there is a significant relation between the nature
of ovarian response and pregnancy rates (Table 2). Never-
theless, antral follicle counts cannot be applied to predict
pregnancy (cycle 1 antral follicle count: P.53; cycle 2
antral follicle count: P.88).
The present study demonstrated that the number of antral
follicles on cycle day 3 varies from cycle to cycle according
to expected fluctuations, especially with higher number of
antral follicles. This does not exclude the possibility of
biologic variation in cohort sizes between cycles. The pre-
dictive accuracy with regard to poor ovarian response in IVF
demonstrated little intercycle variation. Starting off with
either the first or the second antral follicle count, however, it
appeared that the highest count from two cycles gave a
statistically significant improvement of the prediction of
poor response. Does this finding imply clinical relevance of
counting antral follicles in two different cycles instead of
only in one cycle?
Before answering this question, one should consider how
the predictive information might influence the clinical deci-
sion on whether or not to treat, or, if treatment is to be
applied, on whether or not to differentiate the treatment
protocol. Poor response may result in cycle cancellation
during the course of COH. If oocyte pick-up is performed,
poor response is clearly related to low pregnancy rates (Ta-
ble 2). Therefore, the knowledge that a patient will probably
have a poor response may lead to counsel this patient on her
meager prospects. In addition, the treatment protocol may be
altered by applying higher doses of gonadotropins in false
negatives.
On the other hand, if a normal response is predicted, the
decision on whether or not to perform IVF is not influenced.
Thus, the prediction of poor response may have profound
consequences, whereas the prediction of normal response
does not. Therefore, a false-positive prediction (normal re-
sponse in case of a predicted poor response) followed by
negative counseling, denial of treatment, or increased daily
dosages of gonadotropins and consequently a higher risk of
OHSS, might be considered more serious than a false-neg-
ative prediction (poor response in case of a predicted normal
response). Consequently, in our clinical setting high speci-
ficity and a high positive predictive value are more important
than high sensitivity and a high negative predictive value.
This requirement is only satisfied at low antral follicle counts
(4 follicles or less). The data in Table 4 demonstrate that
specificity and positive predictive value of the highest folli-
cle count are just slightly higher than that of cycle 1 antral
follicle count at low antral follicle counts. This might sug-
gest that the highest antral follicle count is more powerful, at
the expense, however, of substantially decreased sensitivity.
Moreover, to obtain this subtle advantage the whole popu-
lation needs to be tested twice. We conclude, therefore, that
performing antral follicle counts in subsequent cycles to
predict poor response in IVF is not useful.
The analysis thus far is based on the scenario that either
one or two antral follicle counts are performed in all patients
in subsequent cycles. A clinically useful alternative could be
only to perform a second antral follicle count in patients with
an intermediate cycle 1 antral follicle count, who still may be
at risk of poor response. We investigated this sequential
diagnostic scenario in our data and it appeared that in case of
only patients with less than seven antral follicles in the first
cycle would have been subjected to a cycle 2 antral follicle
count (40% of all patients), the same overall predictive
performance would have been obtained. Note that these
results are based on a limited number of patients and should
be tested prospectively.
In conclusion, in this study it appeared that a single antral
follicle count is an adequate predictor of poor ovarian re-
sponse in IVF. The impact of a second antral follicle count
in a subsequent cycle on ovarian response predictions is
statistically significant. Clinical relevance, however, in terms
of changes in specificity and sensitivity is very limited. Thus,
the application of an antral follicle count in different cycles
before IVF is not advocated.
T A B L E 3
Logistic regression analysis for the prediction of poor
response, expressed as odds ratios and area under the
receiver operating characteristic curve (ROCAUC) for age,
infertility diagnosis, and various antral follicle count
variables.
Variable
Odds ratio
(95% CI) P value ROCAUC
Univariate
Age (per year) 1.08 (0.99–1.17) .07 0.61
Infertility diagnosis na .001 0.71
Male 1.00 na na
Tubal 1.96 (0.61–6.32) .26 na
Unexplained 6.86 (2.64–17.83) .001 na
Cycle 1 antral follicle count (n) 0.70 (0.60–0.81) .001 0.87
Cycle 2 antral follicle count (n) 0.71 (0.61–0.82) .001 0.85
Mean antral follicle count (n) 0.67 (0.58–0.81) .001 0.87
Highest antral follicle count (n) 0.68 (0.58–0.79) .001 0.89
Lowest antral follicle count (n) 0.70 (0.60–0.81) .001 0.87
Multivariate
Highest antral follicle count (n) 0.68 (0.58–0.79) .001 0.89
Note: CI  confidence intervals; na  not applicable.
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T A B L E 4
Performance of two antral follicle count variables in the prediction of poor response in IVF.
Cycle 1 antral follicle count
Follicles (n) Patientsa Sens NPV Spec PPV Error rate FP FN
10 70 (58) 0.94 0.96 0.57 0.49 32% 36 2
8 61 (51) 0.92 0.95 0.67 0.54 26% 28 3
6 48 (40) 0.81 0.90 0.77 0.60 22% 19 7
5 41 (34) 0.72 0.88 0.82 0.63 20% 15 9
4 32 (27) 0.61 0.84 0.88 0.69 20% 10 14
3 23 (19) 0.47 0.80 0.93 0.74 21% 6 19
2 14 (12) 0.33 0.77 0.98 0.86 22% 2 24
Highest antral follicle count
10 66 (55) 0.94 0.96 0.62 0.52 30% 32 2
8 54 (45) 0.89 0.94 0.74 0.59 22% 22 4
6 39 (33) 0.75 0.89 0.86 0.69 18% 12 9
5 30 (25) 0.61 0.84 0.90 0.73 18% 8 14
4 23 (19) 0.53 0.82 0.95 0.83 18% 4 17
3 17 (14) 0.39 0.79 0.96 0.82 21% 3 22
2 7 (6) 0.17 0.73 0.99 0.86 26% 1 30
Note: For each cutoff number of antral follicles the number of patients with an antral follicle count equal to or below the cutoff value is given. Sens 
sensitivity; NPV  negative predictive value; Spec  specificity; PPV  positive predictive value; FP  number of false positives; FN  number of false
negatives.
a Values in parentheses are percentages.
Bancsi. Repeated antral follicle counts. Fertil Steril 2004.
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